Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Constellation Brands

The statement of cash flow is where you should start analyzing a company's results.

The Most Important Number to Look at Before Buying a Pot Stock

Cronos Group

Altria

Brand-name companies are finding little early-stage success in the high-growth cannabis industry.

Let's Face It, Marijuana Equity Investments Have Flopped

The week ended on a high note for Canopy Growth.

Cannabis giant Canopy Growth posts earnings surprise

The Canadian cannabis producer trounced analysts' Q3 estimates. Here's how Canopy did it.

3 Key Factors Behind Canopy Growth's Blowout Q3 Results

The company posted meaningful top-line growth and significantly narrowed its net loss during the quarter.

Canopy Growth Crushes Estimates in Q3

Roku

YETI

Virgin Galactic

Roku, Canopy Growth, Virgin Galactic and Yeti were our top stock trades from Friday. With that, here's what the charts look like now.

4 Top Stock Trades for Tuesday: ROKU, CGC, SPCE, YETI

Canopy Growth Corporation (CGC) CEO David Klein on Q3 2020 Results - Earnings Call Transcript

Canada's biggest cannabis producer, Canopy Growth Corp, is conducting a "thorough strategic review" of its production facilities to focus on its most lucrative markets and product lines, company executives said on Friday.

Pot producer Canopy doing 'thorough' review of facilities as it pursues profits

St. Valentine came bearing gifts for Canopy Growth Corporation (NYSE: CGC)(TSX:WEED) shareholders, as the stock traded up following strong results for the third-quarter of fiscal 2020.

Tim Seymour On Canopy Growth's Earnings: 'A Huge Exhale'

The Canadian cannabis producer knocked it out of the park with its third-quarter results.

Why Canopy Growth Stock Is Skyrocketing Today

Canada-based Canopy Growth Corp. (NYSE: CGC) reported third-quarter fiscal 2020 results before markets opened Friday.

Cutting Costs Boosts Canopy Growth Stock

HEXO Corp

MedMen Enterprises Inc.

Tilray Brands

The cannabis industry has a major cash problem.

10 Pot Stocks That Could Run Out of Money in 10 Months (or Less)

U.S.-listed shares of Canadian cannabis companies rallied in premarket trade Friday, after a better-than-expected earnings report from market leader Canopy Growth Corp.   bolstered hopes for the beaten-down sector.

Cannabis shares rally premarket as Canopy's better-than-expected quarter boosts sentiment

Canopy Growth said on Friday it will focus on reducing costs as the pot producer struggles with a slump in weed prices from oversupply and growing expenses that led to a bigger adjusted loss in the quarter.

Canopy Growth promises to focus on cutting costs as losses grow

The U.S.-listed shares of Canopy Growth Corp. CGC, -0.66% WEED, -0.54% rocketed 16% in premarket trading Friday, after the Canada-based cannabis company reported a narrower-than-expected fiscal third-quarter loss and revenue that rose above forecasts, amid strength in business-to-consumer sales.

Canopy Growth's stock soars after narrower-than-expected loss, revenue beat

When it comes to cans, THC levels are likely to be lower than what's on the label.

Aluminum Cans May Reduce the Potency of Cannabis Beverages

CGC stock is likely to languish after its fiscal third-quarter earnings report unless it can prove it's on track to be profitable soon.
The post Earnings Preview: Analysts Expect Canopy Growth’s Revenue to Slump appeared first on InvestorPlace.

Earnings Preview: Analysts Expect Canopy Growth’s Revenue to Slump

American Water Works

Deere & Company

iShares U.S. Healthcare ETF

iShares Dow Jones U.S. ETF

JPMorgan Chase & Co

NextEra Energy

Plug Power

SPDR S&P 500 ETF Trust

Teva Pharmaceutical

Tesla

United States Steel

SPDR S&P Homebuilders ETF

Exxon Mobil

Here's your complete guide on which stocks to buy, depending on who wins the 2020 U.S. Presidential Election.

15 Stocks to Buy Based On The 2020 U.S. Presidential Election

Aphria

It's a question that needs to be asked now more than ever.

Should Investors Avoid Large-Cap Pot Stocks Altogether?

The launch of high-margin edibles, vapes, and infused beverages isn't going according to plan.

4 Ways "Cannabis 2.0" Will Be an Early Disappointment in Canada

Should you expect the unexpected with the Canadian cannabis leader's quarterly update?

3 Potential Surprises to Watch For in Canopy Growth's Q3 Results

Scotts Miracle-Gro

After a brutal year in 2019, cannabis stocks are off to another rough start so far in 2020.

7 Cannabis Stocks To Buy, Sell And Hold

CGC stock has faded again into earnings, and cannabis stocks could see volatility ahead. But any dip is a long-term buying opportunity.

Canopy Growth Stock Remains a Long-Term Buy Ahead of Earnings

Boyd Gaming

Diageo

Raytheon

Almost regardless of what happens these days, the market pushes higher. Impeach the president?

5 Sin Stocks to Buy That May Survive a Massive Market Sell-Off

New CEO David Klein needs to limit his cash burn and save struggling Cannabis 2.0 investments in order for CGC stock to survive.
The post Canopy Growth Needs to Keep Cash High in Order to Survive appeared first on InvestorPlace.

Canopy Growth Needs to Keep Cash High in Order to Survive

News for Canopy Growth Stock (CGC)